Mexican doctor faces breathing difficulty after receiving Pfizer COVID vaccine, admitted to ICU

Published On 2021-01-04 04:00 GMT   |   Update On 2021-01-04 04:00 GMT

Mexico City: Mexican authorities said they are studying the case of a 32-year-old female doctor who was hospitalized after receiving the Pfizer-BioNTech COVID-19 vaccine. The doctor, whose name has not been released, was admitted to the intensive care unit of a public hospital in the northern state of Nuevo Leon after she experienced seizures, difficulty breathing, and a skin...

Login or Register to read the full article

Mexico City: Mexican authorities said they are studying the case of a 32-year-old female doctor who was hospitalized after receiving the Pfizer-BioNTech COVID-19 vaccine.

The doctor, whose name has not been released, was admitted to the intensive care unit of a public hospital in the northern state of Nuevo Leon after she experienced seizures, difficulty breathing, and a skin rash.

Also Read:Delhi govt to provide free Covid-19 vaccine doses

"The initial diagnosis is encephalomyelitis," the Health Ministry said in a statement released on Friday night. Encephalomyelitis is an inflammation of the brain and spinal cord.

The ministry added that the doctor has a history of allergic reactions and said that there is no evidence from clinical trials that anyone has developed an inflammation of the brain after the vaccine's application.

Pfizer and BioNTech could not immediately be reached for comment.

More than 126,500 people have died from COVID-19 in Mexico. The country began distributing the first round of COVID-19 vaccines to healthcare workers on Dec. 24.

Also Read:Pfizer, BioNTech to offer COVID-19 vaccine to volunteers who received placebo by March 1

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News